Transcutaneous Vagus Nerve Stimulation for Attention and Memory
NCT: NCT06723743 · RECRUITING
Brief Summary
This clinical trial aims to evaluate whether transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive brain stimulation method, can improve attention and memory in veterans with traumatic brain injury (TBI) and depression and/or posttraumatic stress disorder (PTSD). The study seeks to answer two main questions: 1. Can active taVNS improve attention and memory compared to sham (placebo) stimulation? 2. Does taVNS affect heart rate variability (HRV)? taVNS delivers a gentle electrical current to the vagus nerve through electrodes placed on the ear, targeting brain areas involved in attention and memory without requiring surgery. This study uses a crossover design, meaning all participants will experience two sessions: one with active taVNS and one with sham stimulation. The sham session feels similar but does not deliver actual stimulation, allowing researchers to compare the two and understand taVNS's effects on the brain. In a single visit, participants will: * Complete eligibility screening (questionnaires and vital signs). * Undergo two sessions (one active and one sham), randomly assigned. * Perform attention tasks before and after each session. * Have their heart rate monitored during the sessions. The findings will help determine whether taVNS could be an effective treatment for improving attention and memory in veterans with TBI.
Frequently Asked Questions
What is Transcutaneous Vagus Nerve Stimulation for Attention and Memory?
Transcutaneous Vagus Nerve Stimulation for Attention and Memory is a clinical trial registered under NCT06723743. Current status: RECRUITING.
What is the status of NCT06723743?
The current status of NCT06723743 (Transcutaneous Vagus Nerve Stimulation for Attention and Memory) is: RECRUITING.
When did Transcutaneous Vagus Nerve Stimulation for Attention and Memory start?
Transcutaneous Vagus Nerve Stimulation for Attention and Memory started on 2026-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.